Navigation Links
Dr. Betty Vohr honored for Early Hearing Detection and Intervention Excellence
Date:3/15/2012

Betty R. Vohr, MD, of Barrington, director of Women & Infants Hospital's Neonatal Follow-Up Clinic and medical director of the Rhode Island Hearing Assessment Program, has been presented with the national Antonia Brancia Maxon Award for Early Hearing Detection and Intervention (EHDI) Excellence. The award was presented at the National EHDI Meeting in St. Louis on March 5, 2012.

A graduate of Albany Medical College, Dr. Vohr has been the national coordinator of the National Institute of Child Health and Human Development Neonatal Research Network follow-up studies since 1990. Dr. Vohr is a member of the American Academy of Pediatrics Task Force on Hearing, The Joint Committee of Infant Hearing (former Chair), and Chair of the Rhode Island Hearing Advisory Committee. Her primary clinical and research interests focus on improving the long-term outcomes of high-risk premature infants and infants with hearing loss. Dr. Vohr is participating in studies investigating the outcomes of premature infants and the outcomes of infants with hearing loss. She has published more than 200 manuscripts in peer-reviewed journals, as well as numerous textbook chapters.

Hearing loss is the most commonly occurring disability in US infants, affecting as many as 20,000 babies a year. The consequences of late detection are significant and can result in lifelong communication, social, psychological, behavioral, and educational problems. Research has shown that babies who are identified with hearing loss and receive intervention services within six months of age outperform (at 40 months) those babies who were identified and received services after six months of age.

In 1993, Rhode Island legislation mandating universal newborn hearing screening took effect, and the Rhode Island Hearing Assessment Program (RIHAP) based at Women & Infants, became the first public health program of its kind in the United States. Since that time, RIHAP has screened 99% of Rhode Island's newborn babies (14,000 annually) for hearing loss at its seven hospitals.

This award honors the career achievements of Dr. Antonia Brancia Maxon to promote effective Early Hearing Detection and Intervention programs for all newborns, infants, and young children. Dr. Maxon was a pioneer in EHDI programs, beginning with her leadership in the Rhode Island Hearing Assessment Project in the late 1980s. She was one of the first to recognize the feasibility and value of universal newborn hearing screening and was a tireless advocate for connecting screening programs with timely and appropriate diagnosis and early intervention.

Her extensive contributions to creating excellent EHDI programs were abruptly ended by a tragic automobile accident in May 2007. In memory of her contributions, an Award for EHDI Excellence is presented each year at the National EHDI Meeting to honor an individual or group of people who have made a noteworthy accomplishment in achieving excellence in EHDI programs nationally or in a particular state or region of the country.

Dr. Vohr said, "Our team at Women & Infants Hospital has been at the forefront of newborn hearing screening, beginning with the work of Dr. Maxon. To have this work recognized is truly humbling."


'/>"/>

Contact: Amy Blustein
ablustein@wihri.org
401-681-2822
Women & Infants Hospital
Source:Eurekalert

Related medicine news :

1. Laser Spine Institute Honored at the Gridiron Greats Night of Champions
2. Lakeside Medical Organization, Dr. Richard Merkin, CEO, Honored by United Chambers of Commerce
3. US Oncology Honored by Texas Governor Perrys Office with Inaugural Governors Business Hall of Fame Award
4. Elizabeth Colston, MD, PhD, of CONNEXION Healthcare, Honored as Rising Star by Healthcare Businesswomens Association
5. Amerigroup CEO James Carlson Honored at Crystal Ball for a Cure Annual Gala
6. WebMD Health Foundation Honored as Leader in Health by CancerCare
7. Five Organizations Receive APAs Psychologically Healthy Workplace Award, Ten Honored for Best Practices
8. UBC scientist honored with BMJs Junior Doctor of the Year Award
9. JDRF Founder, Lee Ducat, To Be Honored at 40th Anniversary Gala in Philadelphia
10. Bright Horizons Honored as Company that Cares for Third Straight Year
11. Enovate Honored as One of the 2010 “Michigan 50 Companies to Watch”
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/24/2016)... ... June 24, 2016 , ... A recent article ... are unfamiliar with. The article goes on to state that individuals are now more ... these less common operations such as calf and cheek reduction. The Los Angeles area ...
(Date:6/24/2016)... ... June 24, 2016 , ... June 19, 2016 is World Sickle ... chronic pain and the benefits of holistic treatments, Serenity Recovery Center of ... Sickle Cell Disease. , Sickle Cell Disease (SCD) is a disorder of the red ...
(Date:6/24/2016)... ... 2016 , ... The Pulmonary Hypertension Association (PHA) learned during ... two significant new grants to support its work to advance research and patient ... recognizing patients, medical professionals and scientists for their work in fighting pulmonary hypertension ...
(Date:6/24/2016)... San Francisco, CA (PRWEB) , ... June 24, ... ... at CitiDent, is now offering micro-osteoperforation for accelerated orthodontic treatment. Dr. Cheng has ... , self-ligating Damon brackets , AcceleDent, and accelerated osteogenic orthodontics. , ...
(Date:6/24/2016)... ... June 24, 2016 , ... Topical BioMedics, Inc, makers of Topricin and MyPainAway Pain Relief Products, ... minimum wage raise to $12 an hour by 2020 and then adjusting it yearly to ... value of the minimum wage, assure the wage floor does not erode again, and make ...
Breaking Medicine News(10 mins):
(Date:6/23/2016)... 23, 2016 Any dentist who has made an ... current process. Many of them do not even offer this ... and high laboratory costs involved. And those who ARE able ... such a high cost that the majority of today,s patients ... Parsa Zadeh , founder of Dental Evolutions Inc. and ...
(Date:6/23/2016)... 23, 2016 Capricor Therapeutics, ... a biotechnology company focused on the discovery, development ... patient enrollment in its ongoing randomized HOPE-Duchenne clinical ... 50% of its 24-patient target. Capricor expects the ... quarter of 2016, and to report top line ...
(Date:6/23/2016)... and BOGOTA, Colombia , June 23, 2016  Astellas today announced the establishment of ... Farma Brasil as the company,s second affiliate in Latin America . ... ... Manager of Astellas Farma Colombia ... ...
Breaking Medicine Technology: